EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples

Elizabeth J Horn iD, Barry Menefee, Anna M Schotthoefer iD, George Dempsey, Matt McArdle, Allison F Weber iD, Cathy De Luca, Bobbi S Pritt iD, John A Branda iD

Journal of Clinical Microbiology · 2026

DOI: 10.1128/jcm.01187-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2026. Verfasst von Elizabeth J Horn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lyme Disease Biobank, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Lyme Disease, Algorithms, Serologic Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anonymous Donor, Bay Area Lyme Foundation, Steven and Alexandra Cohen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current laboratory testing for Lyme disease (LD) relies on serology. We evaluated the performance of standard two-tiered testing (STTT) and modified two-tiered testing (MTTT) algorithms using samples obtained from well-characterized patients with early LD in the U.S. East Coast and Upper Midwest. Participants with signs and symptoms of early LD (cases) and controls were enrolled by Lyme Disease Biobank. We compared the performance of four FDA-cleared STTT or MTTT algorithms using serum samples from 251 participants (107 cases, 69 with a convalescent draw; 144 endemic controls). At the initial blood draw, algorithm sensitivity ranged from 22% to 36%, with specificity ranging from 98% to 100%. MTTT algorithms showed higher sensitivity compared with STTT algorithms ( P ≤ 0.05). One STTT algorithm was less sensitive than the other ( P = 0.035), and there was no significant difference in sensitivity between MTTT algorithms. There was also discordance between algorithms; only 22 of the 45 samples classified as laboratory confirmed by Lyme Disease Biobank testing were positive using all algorithms evaluated. Likelihood of positive two-tiered serology among cases with a suspected erythema migrans (EM) skin lesion increased with longer lesion duration and/or when presenting with >1 constitutional symptom. Participants with suspected EM without constitutional symptoms were unlikely to test positive by any algorithm evaluated. Testing convalescent samples did not improve LD detection, and seroconversion was rare. While MTTT confirmed more early LD cases than STTT, all two-tiered algorithms evaluated were insensitive in this population. Novel diagnostics that improve laboratory confirmation for early LD are urgently needed. IMPORTANCE This study confirms that two-tiered serologic testing algorithms are insensitive in early Lyme disease, particularly within the first 2 weeks after symptom onset or when erythema migrans is not accompanied by constitutional symptoms. It also demonstrates that seroconversion is rare after antibiotic treatment. These results highlight the need for novel diagnostics for early Lyme disease that do not rely on serologic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseAlgorithmsSerologic TestsHumansSensitivity and SpecificityFemaleMaleAdultMiddle AgedAntibodies, BacterialYoung AdultAgedAdolescentBorrelia burgdorferi

Stichwörter der Autor:innen

Lyme diseaseMTTTSTTTbiobankbiorepositorydiagnostic algorithmsseroconversionserologytwo-tiered testing

Substanzen

Antibodies, Bacterial

Autor:innen und Institutionen

  • Lyme Disease Biobank, Portland, Oregon, USA.
  • Gold Standard Diagnostics, Davis, California, USA.
  • Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.
  • East Hampton Family Medicine, East Hampton, New York, USA.
  • Stony Brook University, Stony Brook, New York, USA.
  • Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Elizabeth J Horn, Anna M Schotthoefer, Allison F Weber, Bobbi S Pritt, John A Branda

Förderung

  • Anonymous Donor
  • Bay Area Lyme Foundation
  • Steven and Alexandra Cohen Foundation
  • LymeX Innovation Accelerator, U.S. Department of Health & Human Services (HHS)

Zitieren

APA

Horn, E. J., Menefee, B., Schotthoefer, A. M., Dempsey, G., McArdle, M., Weber, A. F., De Luca, C., Pritt, B. S., & Branda, J. A. (2026). Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01187-25

Vancouver

Horn EJ, Menefee B, Schotthoefer AM, Dempsey G, McArdle M, Weber AF, et al. Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples. Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.01187-25

BibTeX
@article{Horn2026,
  author = {Horn, Elizabeth J and Menefee, Barry and Schotthoefer, Anna M and Dempsey, George and McArdle, Matt and Weber, Allison F and De Luca, Cathy and Pritt, Bobbi S and Branda, John A},
  title = {Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  doi = {10.1128/jcm.01187-25}
}
Kostenlos starten →